Incorporating machine learning into established bioinformatics frameworks

N Auslander, AB Gussow, EV Koonin - International journal of molecular …, 2021 - mdpi.com
The exponential growth of biomedical data in recent years has urged the application of
numerous machine learning techniques to address emerging problems in biology and …

The impact of artificial intelligence in the odyssey of rare diseases

A Visibelli, B Roncaglia, O Spiga, A Santucci - Biomedicines, 2023 - mdpi.com
Emerging machine learning (ML) technologies have the potential to significantly improve the
research and treatment of rare diseases, which constitute a vast set of diseases that affect a …

Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection

C Loucera, M Esteban-Medina, K Rian… - Signal transduction and …, 2020 - nature.com
Drug repurposing is a convenient alternative when the need for new drugs in an unexpected
medical scenario is urgent, as is the case of emerging pathogens. In recent years …

A comprehensive review of computational cell cycle models in guiding cancer treatment strategies

C Ma, E Gurkan-Cavusoglu - NPJ Systems Biology and Applications, 2024 - nature.com
This article reviews the current knowledge and recent advancements in computational
modeling of the cell cycle. It offers a comparative analysis of various modeling paradigms …

A comprehensive database for integrated analysis of omics data in autoimmune diseases

J Martorell-Marugán, R López-Domínguez… - BMC …, 2021 - Springer
Background Autoimmune diseases are heterogeneous pathologies with difficult diagnosis
and few therapeutic options. In the last decade, several omics studies have provided …

Systematic review: drug repositioning for congenital disorders of glycosylation (CDG)

S Brasil, M Allocca, SCM Magrinho, I Santos… - International Journal of …, 2022 - mdpi.com
Advances in research have boosted therapy development for congenital disorders of
glycosylation (CDG), a group of rare genetic disorders affecting protein and lipid …

Artificial intelligence in epigenetic studies: shedding light on rare diseases

S Brasil, CJ Neves, T Rijoff, M Falcão… - Frontiers in Molecular …, 2021 - frontiersin.org
More than 7,000 rare diseases (RDs) exist worldwide, affecting approximately 350 million
people, out of which only 5% have treatment. The development of novel genome …

Mechanistic modeling of the SARS-CoV-2 disease map

K Rian, M Esteban-Medina, MR Hidalgo, C Çubuk… - BioData mining, 2021 - Springer
Here we present a web interface that implements a comprehensive mechanistic model of the
SARS-CoV-2 disease map. In this framework, the detailed activity of the human signaling …

Using mechanistic models for the clinical interpretation of complex genomic variation

M Peña-Chilet, M Esteban-Medina, MM Falco, K Rian… - Scientific reports, 2019 - nature.com
The sustained generation of genomic data in the last decade has increased the knowledge
on the causal mutations of a large number of diseases, especially for highly penetrant …

AI-Driven Drug Discovery for Rare Diseases

A Gangwal, A Lavecchia - Journal of Chemical Information and …, 2024 - ACS Publications
Rare diseases (RDs), affecting 300 million people globally, present a daunting public health
challenge characterized by complexity, limited treatment options, and diagnostic hurdles …